bpc-157 clinical studies dosage human safety trial Here's a nice graphic on that you can hand out How BPC-157 Promotes Faster Bone – bpc 157 human clinical trial

BPC-157 acts primarily on the nitric oxide (NO) system , VEGF-mediated angiogenesis and gastric mucosal protection pathways central to vascular repair, tendon-to-bone healing, and gastrointestinal models

BPC-157 promotes healing by: It is particularly well-studied for tendon-to-bone healing, making it popular among athletes and orthopedic patients

GLP-1 agonists work through similar mechanisms

PubMed Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Sjekavica, I., Djuzel, A.R., Knezevic, M., Sever, A.Z., Lojo, N., Kokot, A., Sever, M., Drmic, D., Seiwerth, S., & Sikiric, P

HCG-like immunoreactivity in schistosomes and Fasciola [PMID: 2622900] Laboratory literature summary: hCG-like immunoreactivity in schistosomes and Fasciola